Dra. Maria A. Blasco Marhuenda –
president of the jury
DA doctor in Biochemistry and Molecular Biology (1993), she is the Director of the CNIO (Spanish National Centre for Cancer Research) and leads its Telomeres and Telomerase group.
Her pioneering research established the fundamental role of telomeres and telomerase in cancer and ageing. She has published nearly 250 scientific articles and has won several awards and distinctions such as the Josef Steiner Cancer Research Award (Switzerland), the prestigious EMBO Gold Medal (European Molecular Biology Organization), the European Körber Science Award (Germany), the 2010 Premio Nacional Santiago Ramón y Cajal award in biological research and the 2016 Premio de la Comunidad de Madrid Miguel Catalán award for her career in research, among others.
Dra. Mercedes Rincón Rincón
Professor in the Department of Medicine – Division of Immunobiology at UVM (University of Vermont). She earned her PhD at the Universidad Autónoma de Madrid and continued her research at the Yale University School of Medicine. She is co-founder of the startup Mitotherapeutix.
She has published 146 articles in major publications such as Science, Immunity and Nature Communications and has served on several panels at the National Institute of Health (NIH). She is the inventor of 2 patents and 3 patents of addition and is a world-renowned immunologist with experience in research fields such as allergies, asthma and arthritis, among others.
Dr. Carlos Macaya Miguel
Head of Cardiology at the Hospital Clínico San Carlos in Madrid and President of the Fundación Española del Corazón (Spanish Heart Foundation).
Professor of Cardiology at the Faculty of Medicine at the Universidad Complutense de Madrid (2001). Deeply involved in cardiovascular clinical management, he created the Instituto Cardiovascular in 1998, where he was director until 2007.
In 2007, he was awarded the Premio Jaime I in medical research by the Premios Rey Jaime I Foundation.
Prof. Lina Badimon Maestro
Director of the Cardiovascular Science Institute (ICCC) and CSIC Professor at the Hospital de la Santa Creu i Sant Pau – Universidad Autónoma de Barcelona (UAB), Instituto de Investigaciones Biomédicas IIB-SPau, Lecturer Adjunct Associate Professor of Medicine – Cardiology at Mount Sinai School of Medicine, New York (USA), Director of Catalana Occidente Chair – UAB, Director of UNESCO Chair in Biomedical Sciences Training and Research and Vice President of Scientific Affairs of the European Society of Cardiology (ESC).
Her research interest is focused on cardiovascular and cardiometabolic diseases, atherosclerosis, thrombosis and ischemic diseases. She has published more than 490 articles in highly rated scientific journals. Her H index is 69.
Dr. Pedro Mata López MD, PhD
President and founder of the Fundación Hipercolesterolemia Familiar (Familial Hypercholesterolemia Foundation)
Specialist in Internal Medicine, President and founder of the Spanish Family Hypercholesterolemia Foundation, President of the Ibero-American Family Hypercholesterolemia Network.
He served as Associate Chief of Internal Medicine at the University Hospital of the Fundación Jiménez Díaz until 2013. He is co-founder and board member of the International Familial Hypercholesterolemia Foundation. As a researcher, he has particular interest in epidemiological clinical and molecular research in Familial Hypercholesterolemia. He was director of the prospective cohort study of HF in Spain (SAFEHEART), a programme designed to understand the prognostic factors and mechanisms that influence the development of coronary heart disease and mortality in people with a genetic diagnosis.
Dr. Salvador Aznar Benitah
Catalan Institute of Research and Advanced Studies (ICREA) and Biomedical Research Institute of Barcelona (IRB Barcelona)
Salvador Aznar Benitah, from the Catalan Institute of Research and Advanced Studies (ICREA) and the Biomedical Research Institute of Barcelona (IRB Barcelona), was chosen for his extensive work in the field of basic research, and in particular for his research on the “Impact of dietary fatty acids on metastasis-initiating cells”. This project aims to delve into recent discoveries on metastasis-initiating cells with high levels of the fatty acid receptor CD36. The research team hopes to obtain essential information on the mechanisms of metastasis and how they are influenced by diet. This point is important since Western diets have a large intake of fatty acids, and metastasis is the leading cause of cancer-related deaths.
Raúl Zamora Ros
Private foundation of the Bellvitge Biomedical Research Institute and of the Catalan Institute of Oncology
Raúl Zamora Ros is part of the team of researchers from the private foundation Bellvitge Biomedical Research institute (IDIBELL). He received this award for his research work in the field of clinical research, and in particular for his research work “Dietary polyphenols and their effects on obesity markers”, which assesses the association between exposure to polyphenols and obesity markers, as well as their effect on health parameters and weight loss during a slimming treatment.
Laura Halpern Serra
Secretary and spokesperson of the Jury